$1.74
0.000.00%
Pre-Market: 6:50 AM EDT
180 Life Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of 180 Life Sciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-0.85 | $ | -10000.0 % |
Jun 2024 | 2024-08-12 | $0.01 | $ | 10000.0 % |
Mar 2024 | 2024-05-15 | $-1.68 | $ | -10000.0 % |
Dec 2023 | 2024-03-25 | $-0.08 | $ | -10000.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
180 Life Sciences (ATNF) is scheduled to report earnings on February 13, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.85, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.